Israel Active

Israel has taken delivery of second-generation coronavirus vaccines, updated to better battle new variants. They are expected to be in clinics by the end of September. The international scientific community is again looking to see how well these new vaccines protect Israelis.

The Israel Cancer Research Fund (ICRF) has awarded 83 cancer research grants (28 new and 55 continuing) worth almost $5 million for the 2022-2023 funding year. ICRF’s funding has now reached 2,730 grants totaling more than $87.5 million.

Israel’s Ibex Medical Analytics (see previously) has launched a new cancer detection platform - Galen 3.0 with improved AI algorithms to detect cancer in prostate, breast and gastric biopsies. It also calculates the aggressiveness of prostate cancer, reducing time and errors.

Tel Aviv University scientists have discovered that brain cells called astrocytes, which normally support brain function, are highjacked by tumors to block the immune system and feed the tumors. The scientists eliminated the astrocytes in the lab, and within days the brain tumors died.

Tel Aviv University researchers have identified two antibodies, TAU-1109 and TAU-2310, from recovered coronavirus patients that are 95% effective in neutralizing Covid-19 variants. When concentrated, they can be the basis for a one-time booster for all.

18-year-old Moriah had just completed a first-aid course with emergency NGO United Hatzalah, when she saw her 6-year-old sister Miriam choking on a candy. Moriah remembered the Heimlich maneuver. Within a few seconds the candy came out and Miriam started breathing once again.

Israeli NGO United Hatzalah in Jerusalem has trained 10 members of the Breslev community from Uman Ukraine, to be Emergency Medical Technicians (EMTs). The new graduates hope to return to Uman and use their acquired skills in the region.

A solution that delays cognitive decline and reduces the risk for dementia can have a huge benefit to society. Israel’s CogniShape sends users three scientifically based 5-minute brain-exercises each day to strengthen the mind and sharpen memory. Thousands of US users are signed up (for free) including this editor.

Israel’s BioChange has developed CellFoam™ technology - a bio-adhesive 3D foam structure that forms a scaffold to stimulate repair of damaged cells. BioChange’s first product is ReGum™ - a regenerative implant, for the treatment of periodontitis in animals. A human version is also in development.

Israel’s Hello Heart (see previously) has launched a new cholesterol management feature. ‘My Cholesterol’ allows users to easily track and understand their cholesterol levels, and provides personalized recommendations, to encourage positive lifestyle changes to improve health.